Importantly, combining simvastatin with the AKR1C3 inhibitor potentiated the growth-inhibitory effects of single drugs and effectively inhibited cell and spheroid growth of castration and enzalutamide resistant PCa cells. The gene discussed is AKR1C3; the disease is posterior cortical atrophy.